Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value

$33.42+0.34 (+1.03%)

Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%

Cadre ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Cadre's ebitda for the twelve months ending Sep 30, 2026 was $101.80M, up 7.9% year over year. For fiscal 2025 it was $85.98M, up 3.4% from the year before. The highest annual figure on record is $85.98M in fiscal 2025.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$85.98M	+3.4%
FY2024	Dec 31, 2024	$83.18M	+15.1%
FY2023	Dec 31, 2023	$72.26M	+123.2%
FY2022	Dec 31, 2022	$32.37M	-50.5%
FY2021	Dec 31, 2021	$65.44M	+1.4%
FY2020	Dec 31, 2020	$64.54M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$34.79M	+44.6%
Q2 FY2026	Jun 30, 2026	$28.63M	+47.9%
Q1 FY2026	Mar 31, 2026	$13.22M	-24.1%
Q4 FY2025	Dec 31, 2025	$25.17M	-24.9%
Q3 FY2025	Sep 30, 2025	$24.05M	+161.7%
Q2 FY2025	Jun 30, 2025	$19.36M	-21.2%
Q1 FY2025	Mar 31, 2025	$17.41M	+9.3%
Q4 FY2024	Dec 31, 2024	$33.50M	+109.0%
Q3 FY2024	Sep 30, 2024	$9.19M	-56.0%
Q2 FY2024	Jun 30, 2024	$24.57M	+23.8%
Q1 FY2024	Mar 31, 2024	$15.92M	+2.8%
Q4 FY2023	Dec 31, 2023	$16.03M	-6.0%
Q3 FY2023	Sep 30, 2023	$20.90M	+46.6%
Q2 FY2023	Jun 30, 2023	$19.85M	+65.5%
Q1 FY2023	Mar 31, 2023	$15.48M	–
Q4 FY2022	Dec 31, 2022	$17.06M	+35.2%
Q3 FY2022	Sep 30, 2022	$14.26M	-4.6%
Q2 FY2022	Jun 30, 2022	$11.99M	-36.6%
Q1 FY2022	Mar 31, 2022	-$10.94M	-157.7%
Q4 FY2021	Dec 31, 2021	$12.61M	-1.6%
Q3 FY2021	Sep 30, 2021	$14.95M	–
Q2 FY2021	Jun 30, 2021	$18.90M	–
Q1 FY2021	Mar 31, 2021	$18.97M	–
Q4 FY2020	Dec 31, 2020	$12.82M	–